Cargando…

The Potential of the Combination of CRISPR/Cas9 and Pluripotent Stem Cells to Provide Human Organs from Chimaeric Pigs

Clinical organ allotransplantation is limited by the availability of deceased human donors. However, the transplantation of human organs produced in other species would provide an unlimited number of organs. The pig has been identified as the most suitable source of organs for humans as organs of an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Wanyou, Dai, Yifan, Mou, Lisha, Cooper, David K. C., Shi, Deshun, Cai, Zhiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394547/ https://www.ncbi.nlm.nih.gov/pubmed/25807262 http://dx.doi.org/10.3390/ijms16036545

Ejemplares similares

Production of α1,3-galactosyltransferase and cytidine monophosphate-N-acetylneuraminic acid hydroxylase gene double-deficient pigs by CRISPR/Cas9 and handmade cloning
por: GAO, Hanchao, et al.
Publicado: (2016)

Generation of complement protein C3 deficient pigs by CRISPR/Cas9-mediated gene targeting
por: Zhang, Wei, et al.
Publicado: (2017)

Screening and Identification of the First Non-CRISPR/Cas9-Treated Chinese Miniature Pig With Defective Porcine Endogenous Retrovirus pol Genes
por: Ma, Yuyuan, et al.
Publicado: (2022)

Circulating Organ-Specific MicroRNAs Serve as Biomarkers in Organ-Specific Diseases: Implications for Organ Allo- and Xeno-Transplantation
por: Zhou, Ming, et al.
Publicado: (2016)

Generation of tryptophan hydroxylase 2 gene knockout pigs by CRISPR/Cas9-mediated gene targeting
por: Li, Ze, et al.
Publicado: (2017)

Expression and Regulation Profile of Mature MicroRNA in the Pig: Relevance to Xenotransplantation
por: Song, Zongpei, et al.
Publicado: (2018)

CRISPR-Cas9 mediated one-step disabling of pancreatogenesis in pigs
por: Wu, Jun, et al.
Publicado: (2017)

Novel Epigenetic Techniques Provided by the CRISPR/Cas9 System
por: Xie, Nina, et al.
Publicado: (2018)

A Novel Hybrid CNN-SVR for CRISPR/Cas9 Guide RNA Activity Prediction
por: Zhang, Guishan, et al.
Publicado: (2020)

The provenance of cells in sarcomas induced in chimaeric mice.
por: Ansell, J. D., et al.
Publicado: (1986)

Protocol for the Generation of Human Pluripotent Reporter Cell Lines Using CRISPR/Cas9
por: Zhong, Aaron, et al.
Publicado: (2020)

Efficient Generation of Myostatin Mutations in Pigs Using the CRISPR/Cas9 System
por: Wang, Kankan, et al.
Publicado: (2015)

Improving transgene expression and CRISPR‐Cas9 efficiency with molecular engineering‐based molecules
por: Zhan, Hengji, et al.
Publicado: (2020)

C-RNNCrispr: Prediction of CRISPR/Cas9 sgRNA activity using convolutional and recurrent neural networks
por: Zhang, Guishan, et al.
Publicado: (2020)

Application of CRISPR Cas Systems for Biosensing
por: Liu, Chung Chiun, et al.
Publicado: (2023)

Exploration of the Lysis Mechanisms of Leukaemic Blasts by Chimaeric T-Cells
por: Laurin, David, et al.
Publicado: (2010)

Radial Symmetry in a Chimaeric Glutamate Receptor Pore
por: Wilding, Timothy J, et al.
Publicado: (2014)

Chimaeric antigen receptor T-cell therapy for tumour immunotherapy
por: Sha, Huan-huan, et al.
Publicado: (2017)

CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells
por: Kim, Eun Ji, et al.
Publicado: (2017)

Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9
por: Haupt, Amanda, et al.
Publicado: (2018)

An Alternate Approach to Generate Induced Pluripotent Stem Cells with Precise CRISPR/Cas9 Tool
por: Javaid, Nasir, et al.
Publicado: (2022)

FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells
por: Caillaud, Amandine, et al.
Publicado: (2022)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

CRISPR/Cas9-Mediated Integration of Large Transgene into Pig CEP112 Locus
por: Li, Guoling, et al.
Publicado: (2019)

Application of CRISPR/Cas9 in Alzheimer’s Disease
por: Lu, Likui, et al.
Publicado: (2021)

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)

AB111. Synthesizing an AND gate genetic circuit for identification of bladder cancer cells based on CRISPR-Cas9
por: Liu, Yuchen, et al.
Publicado: (2014)

Prediction of CRISPR/Cas9 single guide RNA cleavage efficiency and specificity by attention-based convolutional neural networks
por: Zhang, Guishan, et al.
Publicado: (2021)

Modeling Transient Abnormal Myelopoiesis Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology
por: Barwe, Sonali P., et al.
Publicado: (2020)

Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology
por: Mianné, Joffrey, et al.
Publicado: (2020)

Single-born XX /XY chimaeric bulls with normal phenotype
por: Kovacs, A, et al.
Publicado: (1977)

Rewiring cell signalling through chimaeric regulatory protein engineering
por: Wang, Baojun, et al.
Publicado: (2013)

One-step generation of triple gene-targeted pigs using CRISPR/Cas9 system
por: Wang, Xianlong, et al.
Publicado: (2016)

Highly efficient CRISPR/Cas9-mediated transgene knockin at the H11 locus in pigs
por: Ruan, Jinxue, et al.
Publicado: (2015)

Generation of germline ablated male pigs by CRISPR/Cas9 editing of the NANOS2 gene
por: Park, Ki-Eun, et al.
Publicado: (2017)

Generation of PCBP1-deficient pigs using CRISPR/Cas9-mediated gene editing
por: Qi, Chunyun, et al.
Publicado: (2022)

Precision cancer mouse models through genome editing with CRISPR-Cas9
por: Mou, Haiwei, et al.
Publicado: (2015)

CRISPR/Cas9 in Gastrointestinal Malignancies
por: Jefremow, André, et al.
Publicado: (2021)

CRISPR/Cas Technology in Pig-to-Human Xenotransplantation Research
por: Ryczek, Natalia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_td1k1mm10adqcakqfa3c85pt4l